Joseph P. Lyssikatos

Chief Scientific Officer at Enliven Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.

Enliven Therapeutics Inc. Director · CHIEF SCIENTIFIC OFFICER
3 years · Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 12, 2026 Enliven Therapeutics Inc. Grant or award +18,750 — —
Feb 6, 2026 Enliven Therapeutics Inc. Open-market sale −5,000 $29.04 $145,200
Jan 20, 2026 Enliven Therapeutics Inc. Open-market sale −5,491 $26.37 $144,798
Jan 20, 2026 Enliven Therapeutics Inc. Open-market sale −14,509 $26.90 $390,292
Jan 9, 2026 Enliven Therapeutics Inc. Open-market sale −41,198 $24.90 $1,025,830
Jan 9, 2026 Enliven Therapeutics Inc. Open-market sale −50,000 $29.13 $1,456,500
Jan 8, 2026 Enliven Therapeutics Inc. Open-market sale −7,500 $20.13 $150,975
Jan 8, 2026 Enliven Therapeutics Inc. Open-market sale −33,802 $24.92 $842,346
Dec 19, 2025 Enliven Therapeutics Inc. Open-market sale −5,000 $16.84 $84,200
Nov 19, 2025 Enliven Therapeutics Inc. Open-market sale −12,008 $22.30 $267,778
Nov 19, 2025 Enliven Therapeutics Inc. Open-market sale −492 $23.09 $11,360
Oct 20, 2025 Enliven Therapeutics Inc. Open-market sale −12,500 $22.08 $276,000
Sep 26, 2025 Enliven Therapeutics Inc. Open-market sale −4,000 $20.25 $81,000
Sep 23, 2025 Enliven Therapeutics Inc. Open-market sale −1,500 $20.03 $30,045
Sep 19, 2025 Enliven Therapeutics Inc. Open-market sale −4,870 $19.11 $93,066

Questions about Joseph P. Lyssikatos

What boards is Joseph P. Lyssikatos on?

Joseph P. Lyssikatos sits on the board of Enliven Therapeutics Inc.

How long has Joseph P. Lyssikatos served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.